NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

A Tender Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")

Source
Find a Tender
Type
Framework (Goods)
Duration
23.5 month
Value
£35M-£35M
Sector
HEALTH
Published
23 Aug 2023
Delivery
To 25 Feb 2026 (est.)
Deadline
25 Sep 2023 11:00

Concepts

Location

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 0 suppliers

Description

This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Division

1 Baclofen Intrathecal Injections
  • Value: £49K

Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single Framework Participant. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
2 Oxycodone Injections
  • Value: £645K

The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single Framework Participant. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection
  • Value: £1M

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single Framework Participant. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
4 Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets
  • Value: £231K

The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
5 Buprenorphine Patches
  • Value: £339K

The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
6 Fentanyl Tablets (Sublingual)
  • Value: £308K

The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
7 Fentanyl Sf Tablet (Buccal)
  • Value: £4K

Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
8 Lot 8 - Fentanyl Transdermal Patch
  • Value: £198K

Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
9 Hydromorphone
  • Value: £100K

Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
10 Lidocaine Chlorhexidine Gel
  • Value: £1M

Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
11 Morphine Sulfate Modified-Release capsule (12Hr)
  • Value: £58K

Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
12 Morphine Sulfate Modified-Release capsule (24Hr)
  • Value: £918

The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
13 Morphine Sulfate Modified-Release Tablet
  • Value: £157K

The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
14 Oxycodone Hydrochloride Capsules
  • Value: £127K

The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
15 Propofol Injection
  • Value: £4M

The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
16 Tramadol Hydrochloride Modified Release Tablets
  • Value: £33K

The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
17 Oxycodone Oral Solution
  • Value: £258K

The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
18 Levobupivacaine (As Hydrochloride) Solution For Infusion
  • Value: £394K

The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of six (6) Framework Participants will be awarded per product line. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95
19 Supply to NHSS Pharmaceuticals "Specials" Service
  • Value: £823K

The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority intends to award this Lot as a single supplier framework agreement per product line. Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Technical (Delivery Schedule) 7.5
Technical (Batch Number) 7.5
Technical (Expiry Date) 5
price 80
20 All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
  • Value: £26M

Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority intends awarding each line within this Lot to a single Framework Participant. Full details of Goods and volumes can be found within the ITT.

Award Criteria
Logistics 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • An E-Auction may be used.
  • This is a one-off contract (no recurrence)
  • Renewals are available.
  • Professional qualifications are sought.
  • Technical restrictions apply.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated values referred to in Section II.1.5 and all Lots covers the twenty-four (24) months framework duration and the twenty-four (24) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 24800. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-pr... A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework/contract. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-com...). (SC Ref:739882)

Reference

Domains